ActRIIB-IN-4 (Compound 10) is an ActRIIB inhibitor with an IC 50 of 4.0 nM. ActRIIB-IN-4 enhances muscle grip strength in tumor cachexia mice.
Products | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Muscle Disease | Products > Signaling Pathways > TGF-beta/Smad | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > TGF-β Receptor
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。